Tyrosine Kinase Inhibitors Market Companies Investing in Product Development to Remain Ahead of the Curve 2019–2025
Typically used as anticancer drugs, tyrosine kinase inhibitors, as the name suggests, inhibit tyrosine kinase enzymes that take the responsibility of the activation of several proteins by signal transduction cascades. A number of tyrosine kinase inhibitors have been proven to be effective as anti-leukemic and anti-tumor agents. Increasing investment in research and development activities is expected to set the tone for strong growth of the global tyrosine kinase inhibitors market. In May 2019, it was announced in a press release...
View full press release